Therapeutic uses of recombinant complement protein inhibitors

gan Kalli, Kimberly R., Hsu, Peihong, Fearon, Douglas T.
Cyhoeddwyd yn Springer Semin Immunopathol (1994)

The Immune System in the Pathogenesis of Ovarian Cancer

gan Charbonneau, Bridget, Goode, Ellen L., Kalli, Kimberly R., Knutson, Keith L., DeRycke, Melissa S.
Cyhoeddwyd 2013

Immunity and immune suppression in human ovarian cancer

gan Preston, Claudia C, Goode, Ellen L, Hartmann, Lynn C, Kalli, Kimberly R, Knutson, Keith L
Cyhoeddwyd 2011

Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer

gan White, Kristin L., Rider, David N., Kalli, Kimberly R., Knutson, Keith L., Jarvik, Gail P., Goode, Ellen L.
Cyhoeddwyd 2011

Toward understanding the genetics of regulatory T cells in ovarian cancer

gan DeRycke, Melissa S, Charbonneau, Bridget, Preston, Claudia C, Kalli, Kimberly R, Knutson, Keith L, Rider, David N, Goode, Ellen L
Cyhoeddwyd 2013

Genetic Evidence for Early Peritoneal Spreading in Pelvic High-Grade Serous Cancer

gan Chien, Jeremy, Neums, Lisa, Powell, Alexis F. L. A., Torres, Michelle, Kalli, Kimberly R., Multinu, Francesco, Shridhar, Viji, Mariani, Andrea
Cyhoeddwyd yn Front Oncol (2018)

Folate receptor alpha as a tumor target in epithelial ovarian cancer

gan Kalli, Kimberly R., Oberg, Ann L., Keeney, Gary L., Christianson, Teresa J.H., Low, Philip S., Knutson, Keith L., Hartmann, Lynn C.
Cyhoeddwyd 2008

Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors Following Combination Therapy with Vaccine and Anti-PD-1 Antibody

gan Karyampudi, Lavakumar, Lamichhane, Purushottam, Scheid, Adam D, Kalli, Kimberly R., Shreeder, Barath, Krempski, James W., Behrens, Marshall D, Knutson, Keith L.
Cyhoeddwyd yn Cancer Res (2014)

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival

gan Jatoi, Aminah, Foster, Nathan R., Kalli, Kimberly R., Vierkant, Robert A., Zhang, Zhiying, Larson, Melissa C., Fridley, Brooke, Goode, Ellen L.
Cyhoeddwyd yn BMC Cancer (2015)

Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands

gan He, Wei, Kularatne, Sumith A., Kalli, Kimberly R., Prendergast, Franklyn G., Amato, Robert J., Klee, George G., Hartmann, Lynn C., Low, Philip S.
Cyhoeddwyd 2008

Plasma immune analytes in patients with epithelial ovarian cancer

gan Block, Matthew S., Maurer, Matthew J., Goergen, Krista, Kalli, Kimberly R., Erskine, Courtney L., Behrens, Marshall D., Oberg, Ann L., Knutson, Keith L.
Cyhoeddwyd yn Cytokine (2015)

Tumor infiltrating PD-1(+) dendritic cells mediate immune suppression in ovarian cancer

gan Krempski, James, Karyampudi, Lavakumar, Behrens, Marshall D., Erskine, Courtney L., Hartmann, Lynn, Dong, Haidong, Goode, Ellen L., Kalli, Kimberly R., Knutson, Keith L.
Cyhoeddwyd 2011

Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancer

gan Carlson, Aaron M., Maurer, Matthew J., Goergen, Krista M., Kalli, Kimberly R., Erskine, Courtney L., Behrens, Marshall D., Knutson, Keith L., Block, Matthew S.
Cyhoeddwyd 2013

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

gan Becker, Marc A., Farzan, Thahir, Harrington, Sean C., Krempski, James W., Weroha, S. John, Hou, Xiaonan, Kalli, Kimberly R., Wong, Tai W., Haluska, Paul
Cyhoeddwyd 2013

Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer

gan Winham, Stacey J., Armasu, Sebastian M., Cicek, Mine S., Larson, Melissa C., Cunningham, Julie M., Kalli, Kimberly R., Fridley, Brooke L., Goode, Ellen L.
Cyhoeddwyd 2014

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

gan Preston, Claudia C., Maurer, Matthew J., Oberg, Ann L., Visscher, Daniel W., Kalli, Kimberly R., Hartmann, Lynn C., Goode, Ellen L., Knutson, Keith L.
Cyhoeddwyd 2013

The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins

gan Li, Zheng, Block, Matthew S., Vierkant, Robert A., Fogarty, Zachary C., Winham, Stacey J., Visscher, Daniel W., Kalli, Kimberly R., Wang, Chen, Goode, Ellen L.
Cyhoeddwyd yn Tumour Biol (2016)

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts()()

gan Butler, Kristina A., Hou, Xiaonan, Becker, Marc A., Zanfagnin, Valentina, Enderica-Gonzalez, Sergio, Visscher, Daniel, Kalli, Kimberly R., Tienchaianada, Piyawan, Haluska, Paul, Weroha, S. John
Cyhoeddwyd yn Neoplasia (2017)

An Integrative Approach to Assess X-Chromosome Inactivation Using Allele-Specific Expression with Applications to Epithelial Ovarian Cancer

gan Larson, Nicholas B., Fogarty, Zachary C., Larson, Melissa C., Kalli, Kimberly R., Lawrenson, Kate, Gayther, Simon, Fridley, Brooke L., Goode, Ellen L., Winham, Stacey J.
Cyhoeddwyd yn Genet Epidemiol (2017)

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

gan Behrens, Marshall D., Wagner, Wolfgang M., Krco, Christopher J., Erskine, Courtney L., Kalli, Kimberly R., Krempski, James, Gad, Ekram A., Disis, Mary L., Knutson, Keith L.
Cyhoeddwyd 2008